You expect .75 based on what news, confirmation that acquisition went through? If yes, then what price targets do you have in mind after the additional milestones are met:
1) Current with OTC filings
2) Announcement that PKG is developing a prototype for the Omentum Device
3) Announcement that clinical trials are expected later this year, or early next year